Proportion of patients without mental disorders being treated in mental health services worldwide.

Br J Psychiatry

Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa

Published: February 2015

Background: Previous research suggests that many people receiving mental health treatment do not meet criteria for a mental disorder but are rather 'the worried well'.

Aims: To examine the association of past-year mental health treatment with DSM-IV disorders.

Method: The World Health Organization's World Mental Health (WMH) Surveys interviewed community samples of adults in 23 countries (n = 62 305) about DSM-IV disorders and treatment in the past 12 months for problems with emotions, alcohol or drugs.

Results: Roughly half (52%) of people who received treatment met criteria for a past-year DSM-IV disorder, an additional 18% for a lifetime disorder and an additional 13% for other indicators of need (multiple subthreshold disorders, recent stressors or suicidal behaviours). Dose-response associations were found between number of indicators of need and treatment.

Conclusions: The vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312965PMC
http://dx.doi.org/10.1192/bjp.bp.113.141424DOI Listing

Publication Analysis

Top Keywords

mental health
16
patients mental
8
mental disorders
8
health treatment
8
disorder additional
8
mental
7
treatment
6
health
5
proportion patients
4
disorders
4

Similar Publications

The current study aims to determine how the interactions between practice (distributed/focused) and mental capacity (high/low) in the cloud-computing environment (CCE) affect the development of reproductive health skills and cognitive absorption. The study employed an experimental design, and it included a categorical variable for mental capacity (low/high) and an independent variable with two types of activities (distributed/focused). The research sample consisted of 240 students from the College of Science and College of Applied Medical Sciences at the University of Hail's.

View Article and Find Full Text PDF

The COVID-19 outbreak, caused by the SARS-CoV-2 virus, was linked to significant neurological and psychiatric manifestations. This review examines the physiopathological mechanisms underlying these neuropsychiatric outcomes and discusses current management strategies. Primarily a respiratory disease, COVID-19 frequently leads to neurological issues, including cephalalgia and migraines, loss of sensory perception, cerebrovascular accidents, and neurological impairment such as encephalopathy.

View Article and Find Full Text PDF

The field of emotion recognition from physiological signals is a growing area of research with significant implications for both mental health monitoring and human-computer interaction. This study introduces a novel approach to detecting emotional states based on fractal analysis of electrodermal activity (EDA) signals. We employed detrended fluctuation analysis (DFA), Hurst exponent estimation, and wavelet entropy calculation to extract fractal features from EDA signals obtained from the CASE dataset, which contains physiological recordings and continuous emotion annotations from 30 participants.

View Article and Find Full Text PDF

Personalized Clustering for Emotion Recognition Improvement.

Sensors (Basel)

December 2024

Instituto de Estudios de Género, Universidad Carlos III de Madrid, Calle Madrid, 126, 28903 Getafe, Spain.

Emotion recognition through artificial intelligence and smart sensing of physical and physiological signals (affective computing) is achieving very interesting results in terms of accuracy, inference times, and user-independent models. In this sense, there are applications related to the safety and well-being of people (sexual assaults, gender-based violence, children and elderly abuse, mental health, etc.) that require even more improvements.

View Article and Find Full Text PDF

Electroencephalography (EEG) has emerged as a pivotal tool in both research and clinical practice due to its non-invasive nature, cost-effectiveness, and ability to provide real-time monitoring of brain activity. Wearable EEG technology opens new avenues for consumer applications, such as mental health monitoring, neurofeedback training, and brain-computer interfaces. However, there is still much to verify and re-examine regarding the functionality of these devices and the quality of the signal they capture, particularly as the field evolves rapidly.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!